>아시아 태평양 생명공학 시장, 제품 유형(기기, 시약 및 서비스 및 소프트웨어), 기술( 나노 생명공학, PCR 기술, DNA 시퀀싱, 크로마토그래피 , 조직 공학 및 재생, 세포 기반 분석, 발효 및 기타), 응용 분야(생물 약학, 생물 산업, 생물 서비스, 생물 정보학 및 생물 농업), 최종 사용자(제약 및 생명 공학 회사, 계약 연구 기관, 학계 및 연구 기관 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타), 국가(중국, 인도, 한국, 호주, 싱가포르, 말레이시아, 태국, 인도네시아, 필리핀, 아시아 태평양 지역 기타 지역) 산업 동향 및 2028년까지의 예측.
시장 분석 및 통찰력: 아시아 태평양 생명공학 시장
생명공학 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 27.9%의 CAGR로 성장하고 있으며 2028년까지 2,691,409.16백만 달러에 도달할 것으로 예상한다고 분석했습니다. 만성 질환의 유병률이 증가함에 따라 첨단 생명공학 제품과 도구가 필요하며 이는 생명공학 시장 성장을 촉진하는 요인입니다.
생명공학은 생물학적 시스템, 생물체 또는 이의 일부를 활용하여 다양한 제품을 개발하거나 만드는 기술입니다. 빵을 양조하고 굽는 것은 생명공학(효모(생물체)를 사용하여 원하는 제품을 생산하는 것)의 개념에 속하는 프로세스의 예입니다. 이러한 전통적인 프로세스는 일반적으로 생물체를 자연 그대로 활용하거나(또는 번식을 통해 더욱 발전시키는) 반면, 보다 현대적인 형태의 생명공학은 일반적으로 생물학적 시스템이나 생물체의 보다 진보된 수정을 포함합니다. 오늘날 생명공학은 다양한 분야(예: 유전학, 생화학, 분자생물학 등)를 포괄합니다. 의학(신약 및 치료법 개발), 농업(유전자 변형 식물, 바이오연료, 생물학적 처리 개발), 산업 생명공학(화학 물질, 종이, 섬유 및 식품 생산) 분야에서 매년 새로운 기술과 제품이 개발됩니다.
생명공학 시장은 만성 질환의 증가와 기술 발전의 증가로 인해 성장하고 있습니다. 게다가 제품 승인의 증가는 생명공학 시장 성장을 가속화하는 또 다른 요인입니다. 숙련된 전문가의 부족은 글로벌 생명공학 시장 성장을 제한할 것으로 예상됩니다.
생명공학 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 생명공학 시장 시나리오를 이해하려면 Data Bridge Market Research에 연락하여 분석가 브리핑을 요청하세요. 당사 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드립니다.
생명공학 시장 범위 및 시장 규모
생명공학 시장은 제품 유형, 기술, 응용 분야, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다. 세그먼트 간 성장은 틈새 성장 포켓과 시장에 접근하고 핵심 응용 분야와 타겟 시장의 차이점을 파악하기 위한 전략을 분석하는 데 도움이 됩니다.
- 제품 유형에 따라 생명공학 시장은 기기, 시약, 서비스 및 소프트웨어로 세분화됩니다. 2021년에는 다양한 혁신적 솔루션의 가용성으로 인해 기기 부문이 생명공학 시장을 지배할 것으로 예상됩니다.
- 기술에 따라 생명공학 시장은 나노바이오기술, PCR 기술, DNA 시퀀싱, 크로마토그래피, 조직 공학 및 재생, 세포 기반 분석, 발효 등으로 세분화됩니다. 2021년에는 나노바이오기술 부문이 광범위한 응용 분야로 인해 생명공학 시장을 지배할 것으로 예상됩니다.
- 응용 프로그램을 기준으로, 생명공학 시장은 생물약학, 생물산업, 생물서비스, 생물정보학, 생물농업으로 세분화됩니다. 2021년에는 연구 개발 활동이 증가함에 따라 생물약학 부문이 생명공학 시장을 지배할 것으로 예상됩니다.
- 최종 사용자를 기준으로 생명공학 시장은 제약 및 생명공학 회사, 계약 연구 기관, 학술 및 연구 기관 등으로 세분화됩니다. 2021년에는 다양한 의료 기관과 정부 기관이 연구 활동을 장려하기 위해 주도적인 활동을 늘리면서 제약 및 생명공학 회사 부문이 생명공학 시장을 지배할 것으로 예상됩니다.
- 유통 채널을 기준으로 글로벌 생명공학 시장은 직접 입찰, 제3자 유통업체 및 기타로 세분화됩니다. 2021년에는 생명공학 기기에 대한 수요가 증가함에 따라 직접 입찰 부문이 생명공학 시장을 지배할 것으로 예상됩니다.
생명공학 시장 국가 수준 분석
생명공학 시장은 제품 유형, 기술, 응용 분야, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다.
생명공학 시장 보고서에서 다루는 국가는 중국, 한국, 일본, 인도, 호주, 싱가포르, 말레이시아, 인도네시아, 태국, 필리핀과 기타 아시아 태평양 지역입니다.
China is leading the growth of the Asia-Pacific market due to presence of highest number of biotechnology products providers.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Biotechnology, is Boosting the Market Growth
The biotechnology market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Biotechnology Market Share Analysis
Biotechnology market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to biotechnology market.
The major companies which are dealing in the biotechnology are Trinity Biotech, Thermo Fisher Scientific Inc., Abbott, F. Hoffmann-La Roche Ltd, Charles River Laboratories, Eurofins Scientific, Promega Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., Takara Bio Inc., Ortho Clinical Diagnostics, QIAGEN, Agilent Technologies, Inc., AstraZeneca, Merck KGaA, bioMérieux SA, Myriad Genetics, Inc., Illumina, Inc., Pacific Biosciences of California, Inc. and Biogen among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the biotechnology market.
For instance,
- In February 2021, Thermo Fisher Scientific Inc. has announced it has completed its previously announced acquisition of Mesa Biotech, Inc. This acquisition anticipated to strengthen company’s leadership in biotechnology market.
- 2021년 3월, Charles River Laboratories는 독점적인 세포 마이크로어레이 기술을 활용한 특수 생물분석 서비스를 제공하는 초기 단계 계약 연구 기관(CRO)인 Retrogenix Limited를 인수했다고 발표했습니다. 이 인수는 회사의 생물분석 사업 부문을 강화할 것으로 예상됩니다.
협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략을 통해 생명공학 시장에서 회사의 입지를 강화하고 조직의 수익 성장에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC BIOTECHNOLOGY MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 ASIA PACIFIC BIOTECHNOLOGY MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 GROWING GERIATRIC POPULATION
5.1.2 GROWING PREVALENCE OF CHRONIC DISEASES
5.1.3 INCREASING TECHNOLOGICAL ADVANCEMENTS
5.1.4 WIDE RANGE OF APPLICATION
5.1.5 RISING FUNDING AND INVESTMENTS FOR THE DEVELOPMENT OF BIOTECHNOLOGY TECHNIQUES
5.2 RESTRAINTS
5.2.1 GROWING PACE OF PRODUCT RECALL
5.2.2 HIGH COST OF BIOTECHNOLOGY INSTRUMENT
5.2.3 STRICT REGULATORY FRAMEWORK
5.3 OPPORTUNITIES
5.3.1 STRATEGIC INITIATIVES BY MAJOR MARKET PLAYERS
5.3.2 ESCALATION IN INNOVATION AND TECHNOLOGIES
5.3.3 RISING EXPENDITURE ON HEALTHCARE
5.4 CHALLENGES
5.4.1 SHORTAGE OF SKILLED PERSONNEL
5.4.2 LIMITATIONS OF DOWNSTREAM PURIFICATION
6 IMPACT OF COVID-19 ON THE ASIA PACIFIC BIOTECHNOLOGY MARKET
6.1 IMPACT ON PRICE
6.2 IMPACT ON DEMAND
6.3 IMPACT ON SUPPLY CHAIN
6.4 STRATEGIC DECISIONS BY MANUFACTURERS
6.5 CONCLUSION
7 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 INSTRUMENT
7.3 REAGENTS
7.4 SERVICES & SOFTWARE
8 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY TECHNOLOGY
8.1 OVERVIEW
8.2 NANO BIOTECHNOLOGY
8.3 NANOCRYSTALS
8.4 NANOPARTICLES
8.5 LIPOSOMES
8.6 MICELLES
8.7 OTHERS
8.8 PCR TECHNOLOGY
8.9 CONVENTIONAL PCR
8.1 REAL-TIME PCR (QPCR)
8.11 DIGITAL PCR (DPCR)
8.12 REVERSE TRANSCRIPTION PCR (RT-PCR)
8.13 OTHER PCR
8.14 DNA SEQUENCING
8.15 SEQUENCING BY SYNTHESIS
8.16 ION SEMICONDUCTOR SEQUENCING
8.17 SEQUENCING BY LIGATION
8.18 PYROSEQUENCING
8.19 SINGLE MOLECULE REAL-TIME SEQUENCING
8.2 CHAIN TERMINATION SEQUENCING
8.21 NANOPORE SEQUENCING
8.22 CHROMATOGRAPHY
8.23 GAS CHROMATOGRAPHY
8.24 LIQUID CHROMATOGRAPHY
8.25 THIN LAYER CHROMATOGRAPHY
8.26 SUPERCRITICAL FLUID CHROMATOGRAPHY
8.27 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY/ULTRA HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC/UHPLC)
8.28 AFFINITY CHROMATOGRAPHY
8.29 TISSUE ENGINEERING AND REGENERATION
8.3 IMMUNOISOLATION TECHNOLOGY
8.31 CELL CULTURE TECHNOLOGY
8.32 STEM CELL TECHNOLOGY
8.33 CELL-BASED ASSAYS
8.34 FLOW CYTOMETRY
8.35 AUTOMATED HANDLING
8.36 LABEL-FREE-DETECTION
8.37 HIGH-THROUGHPUT SCREENING
8.38 OTHERS
8.39 FERMENTATION
8.4 UPSTREAM PROCESS
8.41 DOWNSTREAM PROCESS
8.42 OTHERS
9 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BIOPHARMACY
9.3 BIOINDUSTRIAL
9.4 BIOSERVICES
9.5 BIOINFORMATICS
9.6 BIOAGRICULTURE
10 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 CONTRACT RESEARCH ORGANIZATIONS
10.4 ACADEMIC & RESEARCH INSTITUTES
10.5 OTHERS
11 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY REGION
12.1 ASIA-PACIFIC
12.1.1 CHINA
12.1.2 JAPAN
12.1.3 INDIA
12.1.4 SOUTH KOREA
12.1.5 AUSTRALIA
12.1.6 SINGAPORE
12.1.7 THAILAND
12.1.8 MALAYSIA
12.1.9 INDONESIA
12.1.10 PHILIPPINES
12.1.11 VIETNAM
12.1.12 REST OF ASIA-PACIFIC
13 ASIA PACIFIC BIOTECHNOLOGY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.2 F. HOFFMANN-LA ROCHE LTD
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENT
15.3 ASTRAZENECA
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 MERCK KGAA
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 ABBOTT
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENTS
15.6 AGILENT TECHNOLOGIES, INC.
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BIOGEN
15.7.1 COMPANY SNAPSHOT
15.7.2 REVENUE ANALYSIS
15.7.3 PRODUCT PORTFOLIO
15.7.4 RECENT DEVELOPMENT
15.8 BIOMÉRIEUX SA
15.8.1 COMPANY SNAPSHOT
15.8.2 REVENUE ANALYSIS
15.8.3 PRODUCT PORTFOLIO
15.8.4 RECENT DEVELOPMENTS
15.9 BIO-RAD LABORATORIES, INC.
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENTS
15.1 CHARLES RIVER LABORATORIES
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 EUROFINS SCIENTIFIC
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 ILLUMINA, INC.
15.12.1 COMPANY SNAPSHOT
15.12.2 REVENUE ANALYSIS
15.12.3 PRODUCT PORTFOLIO
15.12.4 RECENT DEVELOPMENT
15.13 MYRIAD GENETICS, INC.
15.13.1 COMPANY SNAPSHOT
15.13.2 REVENUE ANALYSIS
15.13.3 PRODUCT PORTFOLIO
15.13.4 RECENT DEVELOPMENTS
15.14 ORTHO CLINICAL DIAGNOSTICS.
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUE ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENTS
15.15 PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
15.15.1 COMPANY SNAPSHOT
15.15.2 REVENUE ANALYSIS
15.15.3 PRODUCT PORTFOLIO
15.15.4 RECENT DEVELOPMENTS
15.16 PERKINELMER INC.
15.16.1 COMPANY SNAPSHOT
15.16.2 REVENUE ANALYSIS
15.16.3 PRODUCT PORTFOLIO
15.16.4 RECENT DEVELOPMENTS
15.17 PROMEGA CORPORATION
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.18 TAKARA BIO INC.
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENTS
15.19 TRINITY BIOTECH
15.19.1 COMPANY SNAPSHOT
15.19.2 REVENUE ANALYSIS
15.19.3 PRODUCT PORTFOLIO
15.19.4 RECENT DEVELOPMENTS
15.2 QIAGEN
15.20.1 COMPANY SNAPSHOT
15.20.2 REVENUE ANALYSIS
15.20.3 PRODUCT PORTFOLIO
15.20.4 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
표 목록
TABLE 1 ASIA PACIFIC CANCER INCIDENCE IN BOTH THE GENDERS (2018)
TABLE 2 ASIA PACIFIC CANCER INCIDENCE IN MEN (2018)
TABLE 3 ASIA PACIFIC CANCER INCIDENCE IN WOMEN (2018)
TABLE 4 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 5 ASIA PACIFIC INSTRUMENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 ASIA PACIFIC REAGENTS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 ASIA PACIFIC SERVICES & SOFTWARE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 9 ASIA PACIFIC NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 ASIA PACIFIC NANO BIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 11 ASIA PACIFIC PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 ASIA PACIFIC PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 13 ASIA PACIFIC DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 ASIA PACIFIC DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 15 ASIA PACIFIC CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 ASIA PACIFIC CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 17 ASIA PACIFIC TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 ASIA PACIFIC TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 19 ASIA PACIFIC CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 ASIA PACIFIC CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 21 ASIA PACIFIC FERMENTATION IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 ASIA PACIFIC FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 23 ASIA PACIFIC OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 ASIA PACIFIC BIOPHARMACY IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 ASIA PACIFIC BIOINDUSTRIAL IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 ASIA PACIFIC BIOSERVICES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 ASIA PACIFIC BIOINFORMATICS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 ASIA PACIFIC BIOAGRICULTURE IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 31 ASIA PACIFIC PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 ASIA PACIFIC CONTRACT RESEARCH ORGANIZATIONS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 ASIA PACIFIC ACADEMIC & RESEARCH INSTITUTES IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 ASIA PACIFIC OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 ASIA PACIFIC BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 36 ASIA PACIFIC DIRECT TENDER IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 37 ASIA PACIFIC THIRD PARTY DISTRIBUTORS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 ASIA PACIFIC OTHERS IN BIOTECHNOLOGY MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 ASIA-PACIFIC BIOTECHNOLOGY MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 40 ASIA-PACIFIC BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 41 ASIA-PACIFIC BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 42 ASIA-PACIFIC FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 43 ASIA-PACIFIC TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 44 ASIA-PACIFIC PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 45 ASIA-PACIFIC NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 46 ASIA-PACIFIC CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 47 ASIA-PACIFIC DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 48 ASIA-PACIFIC CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 49 ASIA-PACIFIC BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 ASIA-PACIFIC BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 ASIA-PACIFIC BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 CHINA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 53 CHINA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 54 CHINA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 55 CHINA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 56 CHINA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 57 CHINA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 58 CHINA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 59 CHINA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 60 CHINA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 61 CHINA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 62 CHINA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 63 CHINA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 64 JAPAN BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 65 JAPAN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 66 JAPAN FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 67 JAPAN TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 68 JAPAN PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 69 JAPAN NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 70 JAPAN CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 71 JAPAN DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 72 JAPAN CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 73 JAPAN BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 JAPAN BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 75 JAPAN BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 76 INDIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 77 INDIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 78 INDIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 79 INDIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 80 INDIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 81 INDIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 82 INDIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 83 INDIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 84 INDIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 85 INDIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 INDIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 INDIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 88 SOUTH KOREA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 89 SOUTH KOREA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 90 SOUTH KOREA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 91 SOUTH KOREA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 92 SOUTH KOREA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 93 SOUTH KOREA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 94 SOUTH KOREA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 95 SOUTH KOREA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 96 SOUTH KOREA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 97 SOUTH KOREA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 98 SOUTH KOREA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 99 SOUTH KOREA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 100 AUSTRALIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 101 AUSTRALIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 102 AUSTRALIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 103 AUSTRALIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 104 AUSTRALIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 105 AUSTRALIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 106 AUSTRALIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 107 AUSTRALIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 108 AUSTRALIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 109 AUSTRALIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 110 AUSTRALIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 111 AUSTRALIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 112 SINGAPORE BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 113 SINGAPORE BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 114 SINGAPORE FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 115 SINGAPORE TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 116 SINGAPORE PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 117 SINGAPORE NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 118 SINGAPORE CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 119 SINGAPORE DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 120 SINGAPORE CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 121 SINGAPORE BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 122 SINGAPORE BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 123 SINGAPORE BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 124 THAILAND BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 125 THAILAND BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 126 THAILAND FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 127 THAILAND TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 128 THAILAND PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 129 THAILAND NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 130 THAILAND CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 131 THAILAND DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 132 THAILAND CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 133 THAILAND BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 134 THAILAND BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 135 THAILAND BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 136 MALAYSIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 137 MALAYSIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 138 MALAYSIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 139 MALAYSIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 140 MALAYSIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 141 MALAYSIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 142 MALAYSIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 143 MALAYSIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 144 MALAYSIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 145 MALAYSIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 146 MALAYSIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 147 MALAYSIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 148 INDONESIA BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 149 INDONESIA BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 150 INDONESIA FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 151 INDONESIA TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 152 INDONESIA PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 153 INDONESIA NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 154 INDONESIA CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 155 INDONESIA DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 156 INDONESIA CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 157 INDONESIA BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 158 INDONESIA BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 159 INDONESIA BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 160 PHILIPPINES BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 161 PHILIPPINES BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 162 PHILIPPINES FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 163 PHILIPPINES TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 164 PHILIPPINES PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 165 PHILIPPINES NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 166 PHILIPPINES CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 167 PHILIPPINES DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 168 PHILIPPINES CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 169 PHILIPPINES BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 170 PHILIPPINES BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 171 PHILIPPINES BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 172 VIETNAM BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 173 VIETNAM BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 174 VIETNAM FERMENTATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 175 VIETNAM TISSUE ENGINEERING AND REGENERATION IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 176 VIETNAM PCR TECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 177 VIETNAM NANOBIOTECHNOLOGY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 178 VIETNAM CHROMATOGRAPHY IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 179 VIETNAM DNA SEQUENCING IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 180 VIETNAM CELL-BASED ASSAYS IN BIOTECHNOLOGY MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)
TABLE 181 VIETNAM BIOTECHNOLOGY MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 182 VIETNAM BIOTECHNOLOGY MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 183 VIETNAM BIOTECHNOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 184 REST OF ASIA-PACIFIC BIOTECHNOLOGY MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
그림 목록
FIGURE 1 ASIA PACIFIC BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC BIOTECHNOLOGY MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC BIOTECHNOLOGY MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC BIOTECHNOLOGY MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC BIOTECHNOLOGY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC BIOTECHNOLOGY MARKET: MULTIVARIATE MODELLING
FIGURE 7 ASIA PACIFIC BIOTECHNOLOGY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 ASIA PACIFIC BIOTECHNOLOGY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 ASIA PACIFIC BIOTECHNOLOGY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC BIOTECHNOLOGY MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 ASIA PACIFIC BIOTECHNOLOGY MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE ASIA PACIFIC BIOTECHNOLOGY MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 GROWING PREVALENCE OF CHRONIC DISEASES IS DRIVING THE ASIA PACIFIC BIOTECHNOLOGY MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 INSTRUMENTS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC BIOTECHNOLOGY MARKET IN 2021 & 2028
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC BIOTECHNOLOGY MARKET
FIGURE 16 CANCER DEATH RATES BY AGE GROUP (2017)
FIGURE 17 NUMBER OF NEW CANCER CASES FOR ALL AGE GROUPS (IN 2018)
FIGURE 18 NUMBER OF NEW CASES IN MALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 19 NUMBER OF NEW CASES IN FEMALES FOR ALL AGE GROUPS (IN 2018)
FIGURE 20 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2020
FIGURE 21 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 22 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 23 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 24 ASIA PACIFIC BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2020
FIGURE 25 ASIA PACIFIC BIOTECHNOLOGY MARKET : BY TECHNOLOGY, 2021-2028 (USD MILLION)
FIGURE 26 ASIA PACIFIC BIOTECHNOLOGY MARKET : BY TECHNOLOGY, CAGR (2021-2028)
FIGURE 27 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY TECHNOLOGY, LIFELINE CURVE
FIGURE 28 ASIA PACIFIC BIOTECHNOLOGY MARKET : BY APPLICATION, 2020
FIGURE 29 ASIA PACIFIC BIOTECHNOLOGY MARKET : BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 30 ASIA PACIFIC BIOTECHNOLOGY MARKET : BY APPLICATION, CAGR (2021-2028)
FIGURE 31 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 32 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY END USER, 2020
FIGURE 33 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 34 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY END USER, CAGR (2021-2028)
FIGURE 35 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY END USER, LIFELINE CURVE
FIGURE 36 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 37 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 38 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 39 ASIA PACIFIC BIOTECHNOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 40 ASIA-PACIFIC BIOTECHNOLOGY MARKET: SNAPSHOT (2020)
FIGURE 41 ASIA-PACIFIC BIOTECHNOLOGY MARKET: BY COUNTRY (2020)
FIGURE 42 ASIA-PACIFIC BIOTECHNOLOGY MARKET: BY COUNTRY (2021 & 2028)
FIGURE 43 ASIA-PACIFIC BIOTECHNOLOGY MARKET: BY COUNTRY (2020 & 2028)
FIGURE 44 ASIA-PACIFIC BIOTECHNOLOGY MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 45 ASIA PACIFIC BIOTECHNOLOGY MARKET: COMPANY SHARE 2020 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
